BioReference Laboratories
BioReference Labs Acquires US Ariosa Lab NIPT Business From Roche
The business will complement BioReference's specialty health division GenPath, which offers a noninvasive prenatal screening test.
Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent
The firm saw increases in SARS-CoV-2, clinical, and genomic testing and processed approximately 2.8 million COVID-19 PCR tests.
Opko Health Q1 Revenues More Than Double Due to COVID-19 Test Demand
The company reported revenues of $545.2 million compared to $211.5 million in the year-ago quarter, primarily driven by COVID-19 testing.
BioReference Labs Inks Deal to Provide Rapid PCR, Point-of-Care COVID-19 Testing for MLB
The firm is using Mesa Biotech's Accula system for the testing, beginning Thursday, the start of the 2021 MLB season.
Opko Health Q4 Revenues More Than Double Thanks to COVID-19 Testing
The company's service revenues increased 157 percent to $457.9 million due to significant COVID-19 testing volumes, slightly offset by lower base business volumes.
Dec 20, 2020
Oct 30, 2020
Opko Health Q3 Revenues Up 87 Percent
Jun 22, 2018
Apr 24, 2017